Aprea Therapeutics Inc (APRE)
5.85
-0.04
(-0.68%)
USD |
NASDAQ |
May 15, 16:00
5.85
0.00 (0.00%)
After-Hours: 16:27
Aprea Therapeutics Free Cash Flow: -12.27M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -12.27M |
| September 30, 2023 | -12.54M |
| June 30, 2023 | -16.81M |
| March 31, 2023 | -22.49M |
| December 31, 2022 | -25.01M |
| September 30, 2022 | -31.17M |
| June 30, 2022 | -32.81M |
| March 31, 2022 | -31.66M |
| December 31, 2021 | -37.69M |
| Date | Value |
|---|---|
| September 30, 2021 | -40.72M |
| June 30, 2021 | -43.91M |
| March 31, 2021 | -45.80M |
| December 31, 2020 | -41.83M |
| September 30, 2020 | -43.37M |
| June 30, 2020 | -34.75M |
| March 31, 2020 | -30.10M |
| December 31, 2019 | -26.71M |
Free Cash Flow Range, Past 5 Years
-45.80M
Minimum
Mar 2021
-12.27M
Maximum
Dec 2023
-31.16M
Average
-31.66M
Median
Mar 2022
Free Cash Flow Benchmarks
| NeuBase Therapeutics Inc | -14.85M |
| Stoke Therapeutics Inc | -85.74M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.740M |
| Cash from Investing (Quarterly) | -0.0072M |
| Free Cash Flow Per Share (Quarterly) | -1.002 |
| Free Cash Flow Yield | -58.00% |